This is our annual educational webinar on variants of uncertain significance.
Variants of uncertain significance (VUS) are often thought of as an undesirable result in genetic testing. Is there anything one can do to better understand a VUS? As new research becomes available, one might wonder what is required for reclassification of the VUS.
In this educational webinar, Blueprint Genetics’ Laboratory Director Jennifer Schleit, PhD, FACMG, introduces how variants are classified and the next steps to consider with a variant of uncertain significance (VUS).
- Describe how genetic variants are classified
- Examine what variants of uncertain significance mean for patients and providers
- Identify possible next steps for reclassifying variants of uncertain significance
- Share insights on what providers and genetic counselors can do to advance reclassification of variants
Jennifer Schleit, PhD, FACMG, received a PhD in pathology from the University of Washington in Seattle. She completed a clinical fellowship at the University of Washington and received her certification in clinical molecular genetics from the American Board of Medical Genetics and Genomics (ABMGG). Dr Schleit served as an Assistant Director at the Center for Precision Diagnostics at the University of Washington before accepting a position as senior geneticist at Blueprint Genetics in 2017. Her last position at Blueprint Genetics was as Laboratory Director of the Seattle facility until September 2022.